CCHO - Center of Clinical, Health Economics and Outcomes Research

Name

CCHO - Center of Clinical, Health Economics and Outcomes Research

Legal name

CCHO - Center of Clinical, Health Economics and Outcomes Research

Website

https://ccho-ma.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Beirut

HQ country

Lebanon

HQ region

Middle East

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. HEOR and Market Access Consulting Services: CCHO provides professional consulting services including Real World Evidence generation, Patient-Reported Outcomes, Market Access and Health Policy, Economic Modeling, Medical Writing, and Communications and Stakeholder Engagement. These are bespoke, project-based engagements serving pharmaceutical and biotech clients.
2. Education and Training Programs: CCHO offers bespoke training programs in HEOR and market access topics. Programs include expert-led workshops, hybrid learning solutions, and accredited programs. The company also collaborates with Saint Joseph University of Beirut to deliver a 36-credit University Diploma in Health Economics and Outcomes Research over 10 months.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

CCHO is a MENA-focused healthcare consultancy providing seven integrated service lines: Real World Evidence generation, Patient-Reported Outcomes Measures, Market Access and Health Policy strategy, Economic Modeling, Education and Training, Medical Writing, and Communications and Stakeholder Engagement. Engagements are bespoke, project-based consulting offerings tailored to pharmaceutical, biotech, payer, and government clients across the Middle East and North Africa.

Product overview

CCHO is a health economics and outcomes research (HEOR) consultancy operating in the MENA region. The company offers an integrated suite of seven consulting service lines: Real World Evidence (RWE) generation, Patient-Reported Outcomes Measures (PROMs), Market Access and Health Policy, Economic Modeling, Education and Training, Medical Writing, and Communications and Stakeholder Engagement. These services are designed to work together as a comprehensive solution for pharmaceutical market access challenges, from evidence generation through regulatory submissions and stakeholder engagement, all tailored to the MENA healthcare landscape.

Differentiator

Problem solved

Functional benefit

Products and services

• Real World Evidence

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Twelve partnerships are on record, tiered core, major and minor.

• Saint Joseph University of Beirut (USJ)coreStrategic or Co-development Partner · 8 April 2025CCHO collaborates with the Institut Supérieur de Santé Publique (ISSP) at Saint Joseph University of Beirut to deliver the first hybrid University Diploma in Health Economics and Outcomes Research specifically designed for the MENA region. The 36-credit, 10-month program covers applied HEOR principles with a focus on MENA healthcare markets.
• ISPOR King Saud University (KSU) Student ChaptercoreStrategic or Co-development PartnerCCHO collaborated with ISPOR KSU to deliver a 5-part educational series on Health Economics and Outcomes Research (HEOR Essentials). The series brought together over 80 participants from across the MENA region, featuring presentations from CCHO experts and KSU faculty.
• EuroQol GroupcoreTechnology or IntegrationCCHO conducted the EQ-5D-5L Valuation Study in UAE in partnership with EuroQol Group. The study develops a value set for EQ-5D-5L health states based on UAE general population preferences, using the EuroQol Valuation Technology (EQ-VT) protocol.
• United Arab Emirates University (UAEU)coreStrategic or Co-development PartnerCCHO partnered with UAE University for the EQ-5D-5L Valuation Study in UAE. Co-investigators include Dr. Mohamed El Sadig from the Institute of Public Health at UAEU.
• Ministry of Health Saudi ArabiamajorStrategic or Co-development PartnerCCHO co-authored research with Saudi Arabia's Ministry of Health leaders, including a study on 'Implementation of a National Value-Based Insurance Drug Formulary in the Saudi Private Sector' presented at ISPOR Europe 2024.
• Ministry of Health IraqmajorStrategic or Co-development PartnerCCHO collaborated with the Ministry of Health of Iraq on a study assessing direct medical costs of Stage IV NSCLC in Iraq from a public payer perspective, presented at ISPOR Europe 2024.
• Abu Dhabi Health AuthoritymajorStrategic or Co-development PartnerDr. Asma Al Mannaei from Abu Dhabi Health Authority serves as co-investigator on the EQ-5D-5L Valuation Study in UAE.
• Dubai Health AuthoritymajorStrategic or Co-development PartnerDr. Mohamad Farghali from Dubai Health Authority serves as co-investigator on the EQ-5D-5L Valuation Study in UAE.
• World Health Organization (WHO)minorStrategic or Co-development PartnerCCHO team member Jade Khalife has been involved in multi-year projects funded by WHO. The company also mentions WHO expert engagements through team member Dr. Mirna Matni.
• The World BankminorStrategic or Co-development PartnerCCHO team member Jade Khalife has been involved in projects funded by The World Bank related to health systems strengthening in the MENA region.
• Bloomberg PhilanthropiesminorStrategic or Co-development PartnerCCHO team member Jade Khalife has been involved in multi-year projects funded by Bloomberg Philanthropies in the health systems domain.
• Wellcome TrustminorStrategic or Co-development PartnerCCHO team member Jade Khalife has been involved in projects funded by Wellcome Trust.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Analytica Laser: Analytica Laser is a market access and HEOR consultancy with strong European pharma client base and overlapping service lines in health economics modeling and payer engagement, competing for similar pharma consulting mandates.
• OPEN Health (Pharmerit International): OPEN Health, formed around Pharmerit International, is a dedicated HEOR and market access consultancy with comparable service lines (economic modeling, RWE, patient-reported outcomes, market access) and frequently partners with or competes against CCHO on pharma evidence-generation projects.
• Evidera (PPD, Thermo Fisher Scientific): Evidera is a long-standing HEOR, RWE, and market access consultancy within PPD/Thermo Fisher, offering the same suite of HEOR, modeling, PRO, and value-communication services CCHO provides to pharma clients.

Broad incumbents

• McKinsey & Company (Healthcare Practice): McKinsey's healthcare practice advises pharma companies and governments on market access, value-based pricing, and health system reform — overlapping with CCHO's market access and health policy work but at global scale and broader scope.
• ZS Associates: ZS Associates is a global consulting firm with a deep life sciences practice spanning market access, HEOR, real-world evidence, and pricing strategy, frequently competing with CCHO for pharma commercial and access engagements.
• ICON plc: ICON plc acquired Ovation Research Group (where Russell Becker was a Senior Manager) and now offers HEOR, market access, and real-world evidence services globally, making it a broad incumbent competing for the same type of engagements.
• IQVIA: IQVIA is the largest global HEOR/RWE/market access consultancy and routinely competes for the same pharma market access engagements CCHO targets, but at a global scale and with broader service breadth rather than MENA specialization.
• Charles River Associates (CRA): CRA's Life Sciences practice provides health economics, market access, and pricing strategy consulting to pharma clients, overlapping with CCHO's economic modeling and market access offerings at a broader scale.

Regional players

• Deloitte Middle East (Life Sciences & Healthcare): Deloitte's Middle East Life Sciences & Healthcare practice provides market access, pricing, and health-system consulting to pharma clients and government entities in the same geographies CCHO serves, making it a regional incumbent competitor.
• Plug and Play Tech Center (MENA Health): Plug and Play's MENA health program connects regional health startups with corporates and governments, representing an emerging regional player whose corporate-partnership and health-policy network overlaps with CCHO's MENA stakeholder engagement model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/ccho-ma

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CCHO - Center of Clinical, Health Economics and Outcomes Research